 BOSTON and LONDON, March 23, 2022 GLOBE NEWSWIRE -- Centessa Pharmaceuticals plc Nasdaq: CNTA announced today that Saurabh Saha, MD, PhD, Chief Executive Officer, will present at the Guggenheim Genomic Medicines Rare Disease Day on Thursday, March 31, 2022, at 11:00 am Eastern Time. 